Denzin L K, Robbins N F, Carboy-Newcomb C, Cresswell P
Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut 06520-8011, USA.
Immunity. 1994 Oct;1(7):595-606. doi: 10.1016/1074-7613(94)90049-3.
MHC class II molecules expressed in T2 cells fail to acquire a normal complement of endocytically generated peptides. The defect is repaired by introducing HLA-DMA and HLA-DMB cDNA expression vectors, determined by the restoration of SDS stability of class II alpha beta dimers, restoration of a normal conformation for HLA-DR3 as detected by a monoclonal antibody, and by a reduction in class II-associated invariant chain peptides. The intracellular distribution of class II and invariant chain molecules is also restored to that of wild-type cells. The HLA-DMA and HLA-DMB products appear to form a heterodimer that, although transported at least to the medial Golgi, is not expressed at the cell surface. These findings are consistent with HLA-DM functioning intracellularly to facilitate class II-restricted antigen processing.
在T2细胞中表达的MHC II类分子无法获得正常的内吞产生的肽补充。通过引入HLA - DMA和HLA - DMB cDNA表达载体修复该缺陷,这由II类αβ二聚体的SDS稳定性恢复、单克隆抗体检测到的HLA - DR3正常构象恢复以及II类相关恒定链肽的减少来确定。II类和恒定链分子的细胞内分布也恢复到野生型细胞的水平。HLA - DMA和HLA - DMB产物似乎形成了一种异二聚体,尽管其至少转运至高尔基体中部,但未在细胞表面表达。这些发现与HLA - DM在细胞内发挥作用以促进II类限制性抗原加工一致。